SEC 13F Intelligence

Kalehua Capital Management LLC / IKT

Kalehua Capital Management LLC’s Inhibikase Therapeutics Inc Position

Does Kalehua Capital Management LLC own Inhibikase Therapeutics Inc (IKT)? Yes — 6.49M shares worth $11M (+4.20% of its 13F portfolio) as of Q1 2026, up from 1.75M shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
6.49M
% of Portfolio
+4.20%
Quarters Held
2
currently held

Position History IKT

Reported value by quarter
Q4 ’25: $4MQ4 ’25Q1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.49M$11M+4.20%
Q4 20251.75M$4M+3.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kalehua Capital Management LLC’s full portfolio or all institutional holders of IKT.